McLachlan, Donald R. C.
Bergeron, Catherine
Alexandrov, Peter N.
Walsh, William J.
Pogue, Aileen I.
Percy, Maire E.
Kruck, Theodore P. A.
Fang, Zhide
Sharfman, Nathan M.
Jaber, Vivian
Zhao, Yuhai
Li, Wenhong
Lukiw, Walter J.
Funding for this research was provided by:
National Institute on Aging (NIA AG18031 and NIA AG038834)
Article History
Received: 21 November 2018
Accepted: 27 November 2018
First Online: 31 January 2019
Change Date: 23 January 2020
Change Type: Correction
Change Date: 23 January 2020
Change Type: Correction
Change Type: Correction
Change Details: The Editor-in Chief of Molecular Neurobiology has retracted this article [1] at the request of the corresponding author.
Change Details: The Editor-in Chief of Molecular Neurobiology has retracted this article [1] at the request of the corresponding author. This is because it significantly overlaps with their previous publication [2]. Both articles report the same results and as such this article is redundant.
Change Date: 23 January 2020
Change Details: The Editor-in Chief of Molecular Neurobiology has retracted this article [1] at the request of the corresponding author. This is because it significantly overlaps with their previous publication [2]. Both articles report the same results and as such this article is redundant.
Compliance with Ethical Standards
:
: All acquisition, handling, experimental, and analytical procedures involving postmortem human brain tissues were carried out in an ethical manner in strict accordance with the ethics review board policies at brain and tissue donor institutions and at the Louisiana State University (LSU) Health Sciences Center. Informed consent from next of kin was obtained at brain and tissue donor institutions for all tissue samples prior to autopsy and donation; coded postmortem brain tissue samples (containing no personal identifying information of the donors) were obtained from the 18 brain and tissue banks listed in the Acknowledgements section above. The ethical use of postmortem human brain tissues and their analyses were also carried out in strict accordance with the Institutional Biosafety Committee and the Institutional Review Board Committee (IBC/IRBC) ethical guidelines IBC#18059 and IRBC#6774 at the LSU Health Sciences Center, New Orleans LA 70112 USA.
: Declaration of interest for all authors including financial and personal relationships with other people or organizations: none. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. The experimental and research work in this paper was funded by the LSU Eye Center from Research to Prevent Blindness (RPB), the Louisiana Biotechnology Research Network (LBRN), the National Institutes of Health (NIH), Bethesda MD, USA and the Alzheimer Association Chicago IL, USA, and was not supported by any pro- or anti-aluminum lobby or private foundation.